Citations

Clear

1432 citation(s) found for "Uk, Nathan".

Quantitative Imaging System for Cancer Diagnosis and Treatment Planning: An Interdisciplinary Approach
Gaw, Nathan , Xu, Yanzhe , Wang, Lujia , Fu, Yinlin, Silva, Alvin, Zwart, Christine M. , DeLeon, Thomas, Wu, Teresa , Li, Jing , Borad, Mitesh J. , Patel, Bhavika

Mayo Clinic

The Operations Research Revolution | October 4, 2017 | Volume: No volume available | Issue: No issue available | Pages: 152-175

10.1287/educ.2017.0173 Get It

Inorganic nitrate supplementation attenuates peripheral chemoreflex sensitivity but does not improve cardiovagal baroreflex sensitivity in older adults
Bock, Joshua M. , Ueda, Kenichi , Schneider, Aaron , Hughes, William E. , Limberg, Jacqueline K. , Bryan, Nathan S. , Casey, Darren P. , Bock, Joshua , Hughes, William E.

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | October 2, 2017 | Volume: 314 | Issue: 1 | Pages: H45-H51

10.1152/ajpheart.00389.2017 | PMID 28971842 Get It

Aging is associated with increased peripheral chemoreceptor activity, reduced nitric oxide (NO) bioavailability, and attenuation of cardiovagal baroreflex sensitivity (BRS), collectively increasing the risk of cardiovascular disease. Evidence suggests that NO may attenuate peripheral chemoreflex sensitivity and increase BRS. Exogenous inorganic nitrate ([Formula: see text]) increases NO bioavailability via the [Formula: see text]-[Formula: see text]-NO pathway. Our hypothesis was that inorganic [Formula: see text] supplementation would attenuate peripheral chemoreflex sensitivity and enhance spontaneous cardiovagal BRS in older adults. We used a randomized, placebo-controlled crossover design in which 13 older (67 ± 3 yr old) adults ingested beetroot powder containing (BRA) or devoid of (BRP) [Formula: see text] and [Formula: see text] daily over 4 wk. Spontaneous cardiovagal BRS was assessed over 15 min of rest and was quantified using the sequence method. Chemoreflex sensitivity was assessed via ~5 min of hypoxia (10% fraction of inspired O2) and reported as the slope of the relationship between O2 saturation (%[Formula: see text]) and minute ventilation (in l/min) or heart rate (in beats/min). Ventilatory responsiveness to hypoxia was reduced after BRA (from −0.14 ± 0.04 to −0.05 ± 0.02 l·min−1·%[Formula: see text]−1, P = 0.01) versus BRP (from −0.10 ± 0.05 to −0.11 ± 0.05 l·min−1·%[Formula: see text]−1, P = 0.80), with no differences in heart rate responsiveness (BRA: from −0.47 ± 0.06 to −0.33 ± 0.04 beats·min−1·%[Formula: see text]−1, BRP: from −0.48 ± 0.07 to −0.42 ± 0.06 beats·min−1·%[Formula: see text]−1) between conditions (interaction effect, P = 0.41). Spontaneous cardiovagal BRS was unchanged after BRA and BRP (interaction effects, P = 0.69, 0.94, and 0.39 for all, up, and down sequences, respectively), despite a reduction in resting systolic and mean arterial blood pressure in the experimental (BRA) group ( P < 0.01 for both). These findings illustrate that inorganic [Formula: see text] supplementation attenuates peripheral chemoreflex sensitivity without concomitant change in spontaneous cardiovagal BRS in older adults. NEW & NOTEWORTHY Exogenous inorganic nitrate supplementation attenuates ventilatory, but not heart rate, responsiveness to abbreviated hypoxic exposure in older adults. Additionally, inorganic nitrate reduces systolic and mean arterial blood pressure without affecting spontaneous cardiovagal baroreflex sensitivity. These findings suggest that inorganic nitrate may attenuate sympathetically oriented pathologies associated with aging.
Seven tips for developing and maintaining a high performance sports medicine team
Gabbett, Tim J. , Kearney, Simon, Bisson, Leslie J. , Sikka, Robby , Winder, Nathan, Sedgwick, Craig, Hollis, Ed , Bettle, Jeremy M., Collins, Joe T.

Mayo Clinic

British Journal of Sports Medicine | September 27, 2017 | Volume: 52 | Issue: 10 | Pages: 626-627

10.1136/bjsports-2017-098426 | PMID 28954792 Get It

Plasma sphingolipids and depressive symptoms in coronary artery disease
Dinoff, Adam, Saleem, Mahwesh, Herrmann, Nathan , Mielke, Michelle M. , Oh, Paul , Venkata, Swarajya Lakshmi Vattem, Lanctôt, Krista L. , Lanctôt, Krista L , Mielke, Michelle M , Haughey, Norman J.

Mayo Clinic

Brain and Behavior | September 27, 2017 | Volume: 7 | Issue: 11 | Pages: No page available

10.1002/brb3.836 | PMID 29201542 Get It

AbstractBackgroundDepression is highly prevalent in individuals with coronary artery disease (CAD) and increases the risk of future cardiac events and mortality. Sphingolipids have been implicated in the pathophysiology of both CAD and depression. This study assessed the association between plasma sphingolipid concentrations and depressive symptoms in CAD subjects.MethodsDepressive symptoms were measured using the depression subscale of the self‐reported Hospital Anxiety and Depression Scale (HADS). Sphingolipid concentrations were measured from fasting plasma samples using high‐performance liquid chromatography‐coupled electrospray ionization tandem mass spectrometry (LC/MS/MS). Linear regression models were used to assess associations between log‐transformed concentrations of plasma sphingolipids and depressive symptoms.ResultsA total of 111 CAD patients (mean (SD) age = 63.6 ± 6.4, 84.7% male) were included. In linear regression analyses, higher plasma concentrations of ceramides C16:0 (β = 0.204, p = .026) and C18:0 (β = 0.209, p = .023) and sphingomyelin SM18:1 (β = 0.210, p = .024) were significantly associated with higher HADS depression subscale score after adjusting for covariates.ConclusionSphingolipids, in particular the ceramide species C16:0 and C18:0 and the sphingomyelin species SM18:1, may be implicated in the pathophysiology of depression in CAD. The association between plasma sphingolipid concentrations and depression should be further examined in CAD patients and in other populations.
Genome editing technologies and their potential to treat neurologic disease
Madigan, Nicolas N. , Staff, Nathan P. , Windebank, Anthony J. , Benarroch, Eduardo E. , Staff, Nathan P

Mayo Clinic

Neurology | September 21, 2017 | Volume: 89 | Issue: 16 | Pages: 1739-1748

10.1212/wnl.0000000000004558 | PMID 28931646 Get It

Effect of Vascular Injury on Functional Outcome in Knees with Multi-Ligament Injury
Sanders, Thomas L. , Johnson, Nicholas R., Levy, Nathan M., Krych, Aaron J. , Levy, Bruce A. , Krych, Aaron J , Cole, Peter Alexander , Stuart, Michael J.

Mayo Clinic

Journal of Bone and Joint Surgery | September 20, 2017 | Volume: 99 | Issue: 18 | Pages: 1565-1571

10.2106/jbjs.16.01540 | PMID 28926386 Get It

Background: Multi-ligament knee injury (MLKI) associated with knee dislocation can result in vascular injury. The purpose of this study was to compare knee function after MLKI between patients with a vascular injury requiring popliteal artery bypass grafting and patients without vascular involvement. Additionally, factors associated with poor knee function in patients who had MLKI with vascular injury were evaluated. Methods: This retrospective study identified patients with an MLKI between 1992 and 2014. Each patient who had a concomitant vascular injury requiring bypass grafting (vascular cohort, n = 16; mean age, 30.3 years) was matched to 2 patients without a vascular injury (control cohort, n = 32; mean age, 31.4 years) on the basis of age, knee dislocation (KD) grade, and peroneal nerve status. Fifteen patients in the vascular cohort and 26 patients in the control cohort had an isolated knee injury. Functional outcomes were assessed with physical examination of range of motion and ligamentous stability as well as patient-reported outcome scores. Results: The vascular cohort had a mean Lysholm score of 62.5 points (range, 16 to 100 points) and a mean International Knee Documentation Committee (IKDC) score of 59.7 points (range, 14.9 to 100 points) at a mean (and standard deviation) of 8.3 ± 5.0 years after surgery. The control cohort had a mean Lysholm score of 86.4 points (range, 51.0 to 100.0 points) and a mean IKDC score of 83.8 points (range, 35.6 to 100.0 points) at a mean of 6.0 ± 4.0 years. The vascular cohort had significantly lower Lysholm (p = 0.001) and IKDC (p = 0.002) scores than the control cohort. A body mass index (BMI) of >30 kg/m 2 was predictive of lower IKDC (p = 0.0009) and Lysholm (p = 0.0008) scores. Conclusions: Patients who sustain an MLKI with an associated popliteal artery injury requiring bypass grafting have significantly lower knee function scores than patients without vascular involvement. This information can be used to help counsel patients with combined multiple ligament and popliteal artery injuries. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E
Katipamula, Rajini, Jatoi, Aminah , Foster, Nathan R. , Nichols, Francis, Rubin, Joseph, Callister, Matthew D., Gunderson, Leonard L., Nichols, Francis C., Alberts, Steven R.

Mayo Clinic

Clinical medicine. Oncology | September 14, 2017 | Volume: 2 | Issue: No issue available | Pages: No page available

10.4137/cmo.s444 | PMID 21892283 Get It

Purpose This brief report describes a planned, interim, 6-patient toxicity analysis that confirms the safety of pemetrexed, carboplatin, radiation with subsequent surgery, as prescribed in the North Central Cancer Treatment Group trial N044E, in patients with locally advanced esophageal cancer. Methods Six patients with locally advanced, potentially resectable esophageal cancer received pemetrexed 500 mg/m 2 and carboplatin AUC = 6 on days 1 and 22 with 5040 centigray of concomitant radiation in 28 fractions over 5.5 weeks followed by esophagectomy as a prelude to a phase II multi-institutional trial. Results Only 1 of the 6 patients experienced a grade 4 adverse event (neutropenia). This patient also experienced a grade 3 depression. Of the remaining 5 patients, three experienced at least one grade 3 adverse event (neutropenia, nausea/vomiting, and esophagitis). There were no deaths. Incidentally, one patient manifested a complete pathologic response, three a partial pathologic response, and one stable disease. Conclusion These preliminary observations on safety suggest that this regimen can be further studied in this clinical setting.
Should Vital Signs be Routinely Obtained Prior to Intravenous Chemotherapy? Results from a 2-Center Study
Menon, Smitha, Foster, Nathan R. , Looker, Sherry, Sorgatz, Kristine, Jatoi, Aminah , Kasi, Pashtoon Murtaza , McWilliams, Robert R.

Mayo Clinic

Cancer Control | August 30, 2017 | Volume: 22 | Issue: 4 | Pages: 515-519

10.1177/107327481502200419 | PMID 26678980 Get It

A Single-Institution Study of Demographics and Outcomes of Adult Patients with Multiple Cancers
Ho, Thanh P. , Foster, Nathan R. , Jatoi, Aminah

Mayo Clinic

Cancer Control | August 30, 2017 | Volume: 23 | Issue: 4 | Pages: 455-460

10.1177/107327481602300418 | PMID 27842336 Get It

Background Few studies have described the demographics and outcomes in patients with multiple cancers. Methods We reviewed the health records of patients with at least 3 invasive solid-tumor malignancies (lung, colorectal, pancreatic, prostate, breast, or ovarian) diagnosed between 1995 and 2014 at our institution. Results A total of 163 patients were identified. The median age at first cancer diagnosis was 61 years. Sixteen (10%) had a family history of cancer, and 7 (4%) had a cancer-predisposing syndrome. Most had early-stage malignancies and underwent a series of surgical resections. The median survival from the first cancer diagnosis was 14 years (95% confidence interval: 12–16). Forty-three percent developed 4 or more cancers. In univariate analyses, older age, male sex, smoking history, concurrent cancer, and stage IV disease were associated with worse survival; by contrast, breast cancer as the first cancer diagnosis yielded better survival. In multivariate analyses, older age, smoking history, and stage IV disease were associated with worse survival. Conclusions A small group of patients with no ostensible risk factors develop multiple early-stage cancers, receive curative therapy (often surgery), and live for years. These patients merit further study to ascertain the broader prevalence rates of individuals with multiple invasive cancers and to better understand factors that contribute to cancer risk.